Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT02353572 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Principle investigator left the institution

Conditions

Plasma Cell Myeloma
Plasmacytosis
Recurrent Plasma Cell Myeloma
Smoldering Plasma Cell Myeloma

Interventions

DRUG: Melphalan
DRUG: Bortezomib
DRUG: Dexamethasone
PROCEDURE: Autologous Transplant

Sponsor

University of Colorado, Denver